News and Press Releases

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

13 January 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 13, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Revolutionising Delivery and Advancing Sustainability: Capsule innovation and 3D printing transform pharma for a future of precision and ethical solutions.

Dr. Subhashis Chakraborty, General Manager, Head - Global Product Management, ACG Capsules – ACG: “In 2025, advancements in manufacturing technology and polymer science are revolutionising the capsule industry, driving the...

Category: Drug Discovery, Pharmaceutical
Posted: January 13, 2025

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

AbbVie’s SKYRIZI® (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis

Risankizumab will be available on the NHS in Scotland for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to,...

Category: Clinical Trials, Pharmaceutical
Posted: January 13, 2025

AbbVie House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4UB

Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

Approval based on positive pivotal ICARIA-MM phase 3 study using the China-based IsaFiRsT real-world study as bridging data, which demonstrated Sarclisa and the standard treatment Pd, improved responses and long-term...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 13, 2025

One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025 7 January 2025 – Paris, France – Pharmapack Europe & CPHI...

Category: Biotechnology, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: January 13, 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

 Pharmapack Europe: ‘Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and existing biomedical research infrastructure’ 18 December 2024 – Paris, France...

Category: Drug Delivery, Drug Discovery
Posted: January 13, 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France

Paris voted the ‘heart of pharma’ in Europe

Pharmapack Europe research reveals Île-de-France is the second-best location in Europe for ‘drug manufacturing’ and to ‘start a biotech’ Paris, France – The global drug delivery and packaging industry arrives...

Category:
Posted: January 13, 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France

Abu Dhabi to Host Inaugural Pharma Logistics Winter University

The inaugural Pharma Logistics Winter University, co-founded by the Department of Health – Abu Dhabi, Etihad Cargo, Pharma.Aero, the University of Antwerp, and Khalifa University of Science and Technology, offers...

Category: Logistics, Pharmaceutical
Posted: January 13, 2025

Gilead and Leo Pharma Enter into Strategic Partnership to Accelerate Development of Oral STAT6 Program with Potential in Multiple Inflammatory Diseases

Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of LEO Pharma’s Preclinical Oral STAT6 Program, Including Targeted Protein Degraders Gilead Will Have Exclusive Global Rights to the STAT6...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 11, 2025

Phillips Medisize Expands Its Inhalation Drug Delivery Capabilities 

Molex, a parent to Phillips Medisize, Closes Acquisition of Vectura Group Ltd.  Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and production capabilities. ...

Category: Drug Delivery, Manufacturing and Packing
Posted: January 10, 2025

Edisonstraat 1 Hillegom 2181 AB

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

9 January 2025 – Cambridge, United Kingdom and Montreal, Canada – Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for...

Category:
Posted: January 9, 2025

201 President Kennedy Ave., Suite 3900 Montreal, Quebec CANADA H2X 3Y7

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

9 January 2025 -- Cambridge, UK and Montreal, Canada -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 9, 2025

5151 McCrimmon Parkway, Suite 230 Morrisville, NC 27560

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Sarclisa SC formulation added to Pd for the treatment of R/R MM met the co-primary endpoints in the IRAKLIA phase 3 study, demonstrating non-inferiority compared to Sarclisa IV IRAKLIA is...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 9, 2025

One Onslow Street, Guildford, Surrey, GU1 4YS, UK

PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)

Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatment LYT-200...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 9, 2025

PureTech Health 6 Tide Street Boston, MA 02210

DeanHouston Appoints New Director of Hygienic Markets

Jeff Blease brings more than 31 years of industry experience 8 January 2025 -- Kentucky, US -- DeanHouston, a business-first marketing firm that excels at creating meaningful communication strategies for...

Category: Other
Posted: January 8, 2025

525 Scott Street Suite 201 Covington, KY 41011